ReviewComparative immunology, microbiology and infectious diseases2007
Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus.
Review in Comparative immunology, microbiology and infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 42 citations in OpenAlex.
- Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals.International journal of molecular sciences · 2026Article
- Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals.National science review · 2022Article
- Evaluation of Laboratory Management Based on a Combination of TOPSIS and RSR Methods: A Study in 7 Provincial Laboratories of China.Frontiers in public health · 2022Article
- Complementary Effects of Virus Population Are Required for Efficient Virus Infection.Frontiers in microbiology · 2022Article
- Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19.Pathogens (Basel, Switzerland) · 2021Review
- A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.Molecules (Basel, Switzerland) · 2021Review
- The history of the emergence and transmission of human coronaviruses.The Onderstepoort journal of veterinary research · 2021Review
- Advances in developing small molecule SARS 3CLTetrahedron · 2021Review
- Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development.Human vaccines & immunotherapeutics · 2020Review
- High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.Scientific reports · 2020Article
- Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.Molecules (Basel, Switzerland) · 2020Review
- Review
- Analysis of Outbreak and Global Impacts of the COVID-19.Healthcare (Basel, Switzerland) · 2020Article
- Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.Frontiers in medicine · 2020Review
- Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018.Emerging microbes & infections · 2020Article
- For a better world: Biosafety strategies to protect global health.Biosafety and health · 2019Article
- China in action: national strategies to combat against emerging infectious diseases.Science China. Life sciences · 2017Article
- T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.Antiviral research · 2017Review
- Methylene blue covalently attached to single stranded DNA as electroactive label for potential bioassays.Sensors and actuators. B, Chemical · 2014Article
- The construction of a hospital disease tracking and control system with a disease infection probability model.Journal of intelligent manufacturing · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus (SARS-CoV), which has overwhelmed more than 30 countries claiming nearly 8400 cases with over 800 fatalities. Thanks to the unprecedented international collaboration, the whole-genomes of SARS-CoVs were successfully deciphered shortly after the identification of the causative pathogen for outbreak of SARS in southern China, in 2003. Hitherto, the SARS-CoV, as a viral paradigm of emerging infectious entities, has been extensively studied that has ranged from epidemiology, molecular virology/immunology to structural genomics. Also, several lines of breakthroughs have been record-brokenly obtained, that included the finding of ACE2, a functional receptor for the SARS-CoV, solution of the 3CL(pro) structure, a first crystal structure of SARS-related macromolecules, revealing of bats as natural reservoirs for SARS-like viruses and the possible involvement of civet cats in the SARS emergence. This review intends to outline the major progress in the journey of SARS-related exploration, by emphasizing those inaugurated studies with milestone-like significance contributed by Chinese research groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.